ORAMED PHARMACEUTICALS INC.
Recent Filings
All 911 filings →| Form | Description | Date |
|---|---|---|
| 10-K | ANNUAL REPORT | Mar 26, 2026 |
| 4 | — | Mar 18, 2026 |
| 4 | — | Mar 18, 2026 |
| 4 | — | Mar 18, 2026 |
| 4 | — | Mar 18, 2026 |
| 4 | — | Mar 16, 2026 |
| 8-K | 8-K | Feb 20, 2026 |
| SCHEDULE 13D/A | — | Feb 19, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| SCHEDULE 13G/A | — | Feb 9, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Mayer Arie | — | Award / Grant | 6,975 | 133,109 | Jun 5, 2025 |
| Aghion Daniel | — | Award / Grant | 30,000 | 68,820 | Jun 5, 2025 |
| Reznick Yehuda | — | Award / Grant | 30,000 | 60,560 | Jun 5, 2025 |
| Sank Leonard | — | Award / Grant | 6,510 | 134,531 | Jun 5, 2025 |
| Shapiro Benjamin | — | Award / Grant | 30,000 | 85,070 | Jun 5, 2025 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 74,000 | 1,074,666 | Feb 11, 2025 |
| Hexter Joshua | COO & CBO | Award / Grant | 33,334 | 833,167 | Feb 11, 2025 |
| KIDRON NADAV | President and CEO | Award / Grant | 186,000 | 2,586,598 | Feb 11, 2025 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 42,000 | 434,040 | Feb 11, 2025 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 207,000 | 1,000,666 | Jan 2, 2025 |